New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 21, 2014
09:00 EDTKYTHKythera falls 9%
Kythera is down 9%, or $3.86, to $38.98
News For KYTH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 29, 2015
17:22 EDTKYTHAllergan reports 6.7% stake in KYTHERA
10:09 EDTKYTHOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Assured Guaranty (AGO) downgraded to Neutral from Buy at BTIG... Capital Bank (CBF) downgraded to Hold from Buy at Sandler O'Neill... F5 Networks (FFIV) downgraded to Neutral from Overweight at Piper Jaffray... First BanCorp (FBP) downgraded to Neutral from Buy at Guggenheim... Gannett (GCI) downgraded to Hold at Jefferies following spin-off... IBERIABANK (IBKC) downgraded to Hold from Buy at Sandler O'Neill... JPMorgan (JPM) downgraded to Perform from Outperform at Oppenheimer... KYTHERA (KYTH) downgraded to Market Perform from Outperform at Leerink... MBIA (MBI) downgraded to Neutral from Buy at BTIG... Macy's (M) downgraded to Sell from Buy at Deutsche Bank... MarketAxess (MKTX) downgraded to Underperform from Neutral at Macquarie... Nutrisystem (NTRI) downgraded to Market Perform from Outperform at Barrington... Park Sterling Bank (PSTB) downgraded to Hold from Buy at Sandler O'Neill... Popular (BPOP) downgraded to Neutral from Buy at Guggenheim... Qualcomm (QCOM) downgraded to Sell from Hold at Drexel Hamilton... SunTrust (STI) downgraded to Perform from Outperform at Oppenheimer... Ternium (TX) downgraded to Neutral from Buy at BofA/Merrill... Xoom (XOOM) downgraded to Neutral at Susquehanna... Youku Tudou (YOKU) downgraded to Underperform from Neutral at Mizuho.
07:17 EDTKYTHKYTHERA downgraded to Market Perform from Outperform at Leerink
Subscribe for More Information
June 19, 2015
16:24 EDTKYTHStocks end week higher after Fed reassures on gradual pace of rate increases
Subscribe for More Information
10:08 EDTKYTHReceptos jumps amid continued takeover speculation
Speculation of a takeover is again taking shares of Receptos (RCPT) higher. The biopharma company, which has been frequently mentioned as a buyout candidate in blogs and analyst notes, is rumored to have canceled all of its conference appearances. The conference cancelations are unconfirmed, however, and itís not even clear if the company had any scheduled appearances. Further, while KYTHERA (KYTH) was recently acquired after canceling an appearance at a conference, such moves by companies often do not mean acquisition talks are underway. Shares of Receptos are well of their highs but remain up $1.94 to $189.06 in early trading.
09:15 EDTKYTHKYTHERA announces U.S. availability of Kybella
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use